Epilepsy Trial, Recruiting NCT05335187 Sponsor: Pierre Mégevand Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05335187
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older who have focal epilepsy that has not been controlled by medication.
  • People who are being considered as a possible candidate for epilepsy surgery.
  • People whose medical team has determined they need brain monitoring using electrodes placed inside the skull (called stereo-EEG).
  • People who are able and willing to give their formal consent to take part in the trial.

Who may not be able to join:

  • People who currently have an active infection of any kind, such as a fever or throat infection.
  • People who have a skin or scalp infection at the area where the electrodes would be placed.
  • People whose skull bones are too thin or fragile to safely anchor the stereo-EEG electrodes.
  • People who have a higher-than-normal risk of infection, whether due to a medical condition or because they take medication that suppresses the immune system.
  • People who have a higher-than-normal risk of bleeding, whether due to a medical condition or because they take blood-thinning or anti-clotting medication.
  • People who have a serious ongoing illness affecting the heart, lungs, kidneys, or liver.
  • People who have a serious ongoing psychiatric condition or are experiencing major psychological distress.
  • People who are pregnant or breastfeeding during the study period.
  • People who have an implanted electrical device inside their body, such as a pacemaker, defibrillator, or nerve stimulator.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +41 22 379 53 88

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pierre Mégevand
Registry
ClinicalTrials.gov
Start date
30 March 2023
Est. completion
1 September 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Adverse events (safety outcome)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov